Elixir Medical announced three-year results from a large randomized controlled trial of its DynamX coronary bioadaptor system.

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

Abbott's Tendyne transcatheter mitral valve replacement (TMVR) system was approved by the FDA and indicated for those with ...

MILPITAS, Calif., March 18, 2025--(BUSINESS WIRE)--Elixir Medical is proud to have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2025. This year’s ...

Three-year data from Elixir Medical Corp.’s Bioadaptor randomized controlled trial showed that patients with coronary artery ...

Elixir Medical has joined the growing intravascular lithotripsy (IVL) market following the CE marking of its LithiX Hertz Contact system. The LithiX device employs focal stress contact points to ...

In search of a better solution than stents, Elixir Medical has developed the DynamX, which has three helical strands linked together. It is coated in a biodegradable polymer that releases a ...

MILPITAS, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced EU MDR CE Mark approval and commercial ...

Why these 10 medical device makers are the most innovative in the world Why HistoSonics, Heartflow, Xenco Medical, and Virtual Incision are among the most innovative medical device makers of 2025.

Receipt of EU MDR CE mark may not be a magic potion, but Elixir Medical Corp. is certainly feeling a boost from the regulatory nod for its mechanical Lithix hertz contact intravascular lithotripsy ...

Morningstar brands and products Company Portfolio ...

MILPITAS, Calif., March 18, 2025--(BUSINESS WIRE)--Elixir Medical is proud to have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2025. This year’s list ...